Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€492.60

€492.60

0.900%
4.4
0.900%
€520.42
 
19.04.24 / Tradegate WKN: 893953 / Symbol: MCK / Name: McKesson / Stock / Food & Drug Retailing / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

McKesson Corp. Stock

McKesson Corp. gained 0.900% compared to yesterday.
McKesson Corp. is currently one of the favorites of our community with 15 Buy predictions and no Sell predictions.
As a result the target price of 520 € shows a slightly positive potential of 5.56% compared to the current price of 492.6 € for McKesson Corp..

Pros and Cons of McKesson Corp. in the next few years

Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of McKesson Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
McKesson Corp. 0.900% 0.142% 0.122% 51.569% 18.986% 205.583% 388.109%
Cardinal Health Inc. 1.200% 2.763% -2.262% 40.807% 12.833% 99.666% 146.900%
CVS Health Corp. 0.260% 1.425% -8.805% -3.394% -8.626% 3.971% 39.069%
AmerisourceBergen Corp. -0.960% 1.341% -0.045% 46.082% 21.195% 124.070% 247.870%

Comments

Prediction Buy
Perf. (%) 0.10%
Target price 515.339
Change
Ends at 15.04.25

McKesson Co. (NYSE: MCK) had its price target raised by analysts at Morgan Stanley from $522.00 to $548.00. They now have an "overweight" rating on the stock.
Ratings data for MCK provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -0.16%
Target price 531.012
Change
Ends at 10.04.25

McKesson Co. (NYSE: MCK) had its price target raised by analysts at Argus from $510.00 to $570.00. They now have a "buy" rating on the stock.
Ratings data for MCK provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 1.57%
Target price 568.416
Change
Ends at 06.03.25

McKesson Co. (NYSE: MCK) had its price target raised by analysts at UBS Group AG from $575.00 to $620.00. They now have a "buy" rating on the stock.
Ratings data for MCK provided by MarketBeat
Show more

News

McKesson (MCK) Q3 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
McKesson (MCK) Q3 2024 Earnings Call Transcript

Image source: The Motley Fool.

McKesson (NYSE: MCK)Q3 2024 Earnings CallFeb 07, 2024, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks: https://g.foolcdn.com/editorial/images/756811/medical-staff-talk-with-management.jpg
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks

Bigtime medical distributors like McKesson (NYSE: MCK) and Cencora (NYSE: COR) make money by moving drugs and supplies to clinics and pharmacies worldwide. While investors usually look to such

McKesson (MCK) Q2 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
McKesson (MCK) Q2 2024 Earnings Call Transcript

Image source: The Motley Fool.

McKesson (NYSE: MCK)Q2 2024 Earnings CallNov 01, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com